Nobuhiro Takahashi | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. Nobuhiro Takahashi | Medicine and Dentistry | Best Researcher Award

Dermatologist from Tokai University School of Medicine, Japan

Dr. Nobuhiro Takahashi is a dedicated clinical professional specializing in dermatology, with a primary focus on inflammatory skin diseases. Currently serving as a Clinical Assistant in the Department of Dermatology at Tokai University Hospital, Kanagawa, Japan, Dr. Takahashi actively participates in both clinical practice and academic training. He has demonstrated a strong commitment to advancing patient care in outpatient dermatology. His work reflects a growing interest in combining clinical insights with research opportunities. With a solid foundation in medical education and practical experience, Dr. Takahashi shows promise for contributing significantly to dermatological research in the future.

Professional Profile

Education

Dr. Nobuhiro Takahashi completed his medical degree at Tokai University School of Medicine, Japan, graduating in March 2020. His academic training provided him with a comprehensive understanding of medical sciences, with a particular interest in dermatology developing during his studies. The rigorous curriculum at Tokai University laid the groundwork for his clinical reasoning, diagnostic skills, and patient management techniques. His education emphasized both theoretical knowledge and practical application, preparing him effectively for postgraduate clinical training and his current clinical role. Dr. Takahashi’s education continues to support his professional development and potential future contributions to clinical research.

Professional Experience

Dr. Takahashi began his professional journey as a Clinical Resident at Tokai University Hospital, where he completed a two-year postgraduate clinical training program from April 2020 to March 2022. This experience allowed him to build strong diagnostic and treatment skills across multiple medical disciplines. Since April 2022, he has been serving as a Clinical Assistant in the Department of Dermatology at Tokai University. In this role, he focuses on outpatient clinical dermatology and academic training, working closely with specialists to manage a variety of dermatological conditions. His current responsibilities allow him to blend clinical service with ongoing professional growth.

Research Interest

Dr. Takahashi’s primary research interests center around dermatology, particularly the study and management of inflammatory skin diseases. He is focused on improving clinical outcomes and advancing therapeutic strategies for these complex skin conditions. His exposure to diverse patient cases in an outpatient setting provides valuable clinical observations that can guide his research direction. While his current profile does not extensively detail research projects or publications, his interest in bridging clinical practice with academic research is evident. Dr. Takahashi is well-positioned to contribute to future dermatological studies that address common and challenging skin disorders.

Research Skills

Dr. Takahashi has developed a strong set of clinical and observational skills through his extensive outpatient dermatology practice. His ability to diagnose, monitor, and manage various skin conditions equips him with firsthand clinical insights essential for relevant and impactful research. Although specific laboratory or advanced research techniques are not detailed in his profile, his clinical experience supports potential development in clinical research methodologies, case study analysis, and patient-centered research. His ongoing academic training is expected to enhance his research capabilities further, enabling him to contribute to clinical trials and evidence-based dermatology studies.

Award and Honors

At this stage of his career, Dr. Takahashi has not yet received formal awards or honors in the field of dermatology or medical research. His professional achievements thus far reflect his dedication to clinical practice and academic growth. As he continues to develop his research portfolio and engage in scholarly activities, there is significant potential for him to earn recognition in the future. Participation in conferences, collaborative research, and contributions to peer-reviewed publications will likely pave the way for future awards and academic honors that acknowledge his efforts in advancing dermatological science.

Conclusion

In conclusion, Dr. Nobuhiro Takahashi is an emerging clinical dermatologist with a promising future in research. His solid educational background, hands-on clinical experience, and keen interest in inflammatory skin diseases demonstrate his dedication to the field. Although he currently has limited research output and formal recognitions, his trajectory indicates potential for future contributions to dermatological science. With continued clinical engagement, research involvement, and academic participation, Dr. Takahashi can develop into a respected researcher who significantly impacts both patient care and dermatological research. His career is well-positioned for continued growth and achievement.

Publication Top Note

  1. Title: A Case of Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma
  • Journal: JEADV Clinical Practice
  • Year: 2025

 

Jingwen Zhang | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. Jingwen Zhang | Medicine and Dentistry | Best Researcher Award

Research Fellow from The University of Melbourne, Australia

Dr. Jingwen Zhang is an emerging epidemiologist specializing in respiratory health, particularly chronic cough in adults. Currently serving as a Research Fellow at the Allergy and Lung Health Unit, The University of Melbourne, she has demonstrated a strong commitment to impactful public health research. With academic training in clinical medicine, public health, and epidemiology, Dr. Zhang brings a unique multidisciplinary perspective to her work. Her research is recognized at both national and international levels, having received prestigious scholarships, competitive grants, and multiple awards for her presentations. She has published extensively and has provided significant contributions as a peer reviewer for leading journals, including The Lancet and New England Journal of Medicine. Beyond her research, Dr. Zhang is actively engaged in teaching, mentoring postgraduate students, organizing scientific meetings, and participating in collaborative initiatives that aim to advance respiratory health research. Her work has attracted considerable media attention, reflecting its relevance to the broader public. Dr. Zhang’s dedication to improving respiratory health outcomes, her leadership in the research community, and her drive for continuous professional development make her a distinguished figure in the field of epidemiology with great potential for future leadership on a global scale.

Professional Profile

Education

Dr. Jingwen Zhang’s academic journey is a blend of excellence in clinical and public health disciplines. She is currently pursuing her Doctor of Philosophy (Epidemiology) at The University of Melbourne, Australia, from 2019 to 2024. Her research focuses on the epidemiology of adult chronic cough, supported by the prestigious University of Melbourne and China Scholarship Council Joint Scholarship. This scholarship covers her tuition fees and provides a substantial living stipend, reflecting the competitiveness of her candidature. Prior to this, she earned a Master of Public Health with First Class Honours from The University of Melbourne in 2018, showcasing her early academic excellence in the public health domain. Her undergraduate degree in Clinical Medicine, obtained from Qingdao University, China, in 2016, provided her with a strong foundation in medical sciences. This diverse educational background equips her with critical clinical insights and advanced epidemiological skills, making her uniquely capable of translating clinical problems into population-based research solutions. Throughout her studies, Dr. Zhang has actively pursued advanced training and upskilling workshops in contemporary epidemiology, clinical trials, and causal inference, further enhancing her scientific competence and professional readiness to address complex public health issues.

Professional Experience

Dr. Jingwen Zhang’s professional journey is marked by progressive research and academic responsibilities. Since 2023, she has been working as a Research Fellow at the Allergy and Lung Health Unit, The University of Melbourne, contributing to cutting-edge respiratory health research. Between 2021 and 2023, she served as a Research Assistant at the same institution, where she supported numerous projects in chronic cough and lung health epidemiology. Her experience extends to academic teaching as a casual tutor at the Centre for Epidemiology and Biostatistics in 2021, where she taught core epidemiology subjects and developed teaching materials for advanced courses. Earlier in her career, in 2016, she worked as a teacher and administrative officer at Amio International Education in China, which provided her with valuable organizational and communication skills. Dr. Zhang’s career also reflects her active participation in scientific committee meetings, leadership in organizing collaborative research initiatives, and volunteer contributions at major scientific conferences. These experiences demonstrate her dedication to academic service and her capacity for multi-tasking across research, teaching, mentoring, and community engagement. Her sustained involvement in both the academic and clinical research environment showcases her readiness to contribute at a higher level within the international research community.

Research Interest

Dr. Jingwen Zhang’s primary research interest lies in the epidemiology of chronic cough and its broader implications for respiratory health. Her doctoral research focuses on understanding chronic cough phenotypes and identifying occupational and environmental risk factors associated with different cough types among middle-aged adults. She is particularly interested in how long-term exposure to air pollution and other environmental factors contribute to chronic respiratory conditions. Her work also explores the epidemiology of asthma-COPD overlap and interventions to improve lung function among adults and children. Dr. Zhang’s research interests extend to the development of evidence-based clinical and public health strategies for improving lung health outcomes. Additionally, she is committed to applying advanced epidemiological methods, including causal inference, longitudinal data analysis, and systematic reviews, to address pressing public health issues. She is passionate about translating complex research findings into actionable insights that can shape policy, clinical practice, and public awareness. Dr. Zhang is also actively involved in collaborative cohort studies such as TAHS and PRECURSOR, which provide large-scale data for respiratory health research. Through her multi-dimensional research focus, Dr. Zhang aims to bridge the gap between clinical observations and population health interventions, ultimately improving respiratory disease management and prevention strategies.

Research Skills

Dr. Jingwen Zhang possesses a diverse and highly applicable skill set that supports her work in epidemiology and respiratory health research. She is proficient in advanced epidemiological study designs, data cleaning, and statistical analysis, with strong expertise in using statistical software such as R and REDCap. Dr. Zhang has completed specialized training in causal inference, clinical trials, reproducible research, and contemporary epidemiology, equipping her with the methodological tools necessary for high-impact research. She has substantial experience in data management, including cleaning and processing large cohort datasets, spirometry data, and address tracking for environmental exposure studies. Dr. Zhang is also skilled in systematic reviews, meta-analyses, and longitudinal study methodologies. Additionally, she has developed teaching skills through her involvement in tutorials, course material development, and student assessment. Dr. Zhang’s experience extends to manuscript preparation, scientific communication, and peer reviewing for high-ranking journals. Her organizational capabilities are evident through her role in coordinating large research initiatives, managing academic social media platforms, and hosting scientific meetings. With strong analytical thinking, attention to detail, and effective communication, Dr. Zhang’s research skills enable her to contribute meaningfully to multidisciplinary teams and deliver impactful epidemiological research outcomes.

Awards and Honors

Throughout her academic and professional journey, Dr. Jingwen Zhang has received several prestigious awards and honors that recognize her contributions to respiratory epidemiology. In 2022, she won the Best Poster Award at the Thoracic Society of Australia and New Zealand Annual Scientific Meeting for her work on occupational risks associated with novel cough phenotypes. In 2023, she received the Golden Prize at the 4th International Cough Conference for her oral presentation on the associations between air pollutants and cough types in middle-aged adults, a recognition that included funding for accommodation and travel. Dr. Zhang was awarded the University of Melbourne and China Scholarship Council Joint Scholarship, a highly competitive program covering both tuition fees and a generous living stipend for her Ph.D. studies. She also secured the PHIRST Grant in 2021 and multiple travel grants in 2024, including the TSANZ Janet Elder International Travel Award. Dr. Zhang’s excellence extends beyond awards, as she has been invited to review manuscripts for leading journals like The Lancet, Thorax, New England Journal of Medicine, and European Respiratory Journal, showcasing her growing influence in the research community. These accolades reflect her scientific rigor, leadership potential, and dedication to improving public health outcomes.

Conclusion

Dr. Jingwen Zhang exemplifies the qualities of an outstanding early-career researcher with a promising future in the field of epidemiology and respiratory health. Her strong academic foundation, research productivity, and active participation in academic service position her as a rising leader in public health research. Dr. Zhang’s work addresses a critical gap in chronic cough epidemiology and contributes valuable knowledge with the potential to influence clinical guidelines and public health policies. She has successfully combined rigorous research with impactful community engagement and international scientific dissemination. Her role as a mentor and organizer further demonstrates her leadership and commitment to building collaborative research environments. With further opportunities to expand international collaborations, increase first-author publications in top-tier journals, and lead larger research grants, Dr. Zhang is well-positioned to achieve global recognition in her field. Her comprehensive skill set, exceptional dedication, and passion for improving respiratory health outcomes make her a highly deserving candidate for prestigious research awards and continued academic advancement. Dr. Zhang’s career trajectory reflects not only her scientific excellence but also her potential to drive meaningful change in public health both nationally and internationally.

Publications Top Notes

1. Associations Between Occupational Exposures and Cough Subclasses Among Middle‐Aged Australians

  • Authors: Jingwen Zhang, Jennifer L. Perret, Dinh S. Bui, Sheikh M. Alif, Michael J. Abramson, Anne B. Chang, Hans Kromhout, Garun S. Hamilton, Paul S. Thomas, Bircan Erbas, et al.

  • Year: 2025

2. Chronic Bronchitis in Children and Adults: Definitions, Pathophysiology, Prevalence, Risk Factors, and Consequences

  • Authors: Jingwen Zhang, Danielle F. Wurzel, Jennifer L. Perret, Caroline J. Lodge, E. Haydn Walters, Shyamali C. Dharmage

  • Year: 2024

3. Association of Novel Adult Cough Subclasses With Clinical Characteristics and Lung Function Across Six Decades of Life in a Prospective, Community-Based Cohort in Australia: An Analysis of the Tasmanian Longitudinal Health Study (TAHS)

  • Authors: Jingwen Zhang, Caroline J. Lodge, E. Haydn Walters, Anne B. Chang, Dinh S. Bui, Adrian J. Lowe, Garun S. Hamilton, Paul S. Thomas, Chamara V. Senaratna, Alan L. James, et al.

  • Year: 2024

4. A Review of the Role of Pollen in COVID-19 Infection

  • Authors: Nur Sabrina Idrose, Jingwen Zhang, Caroline J. Lodge, Bircan Erbas, Jo A. Douglass, Dinh S. Bui, Shyamali C. Dharmage

  • Year: 2023

5. Risk Factors for Chronic Cough in Adults: A Systematic Review and Meta‐Analysis

  • Authors: Jingwen Zhang, Jennifer L. Perret, Anne B. Chang, Nur S. Idrose, Dinh S. Bui, Adrian J. Lowe, Michael J. Abramson, E. Haydn Walters, Caroline J. Lodge, Shyamali C. Dharmage

  • Year: 2022

6. Serum Cytokine Concentrations and Asthma Persistence to Middle Age

  • Authors: Jingwen Zhang, Eugene H. Walters, Mimi L. K. Tang, Adrian J. Lowe, Caroline J. Lodge, Dinh Bui, Rangi Kandane‐Rathnayake, Bircan Erbas, Garun S. Hamilton, Bruce R. Thompson, et al.

  • Year: 2020

Ren Guibing | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Assoc. Prof. Dr. Ren Guibing | Medicine and Dentistry | Best Researcher Award

Associate Chief Physician from Department of Oncology, Characteristic Medical Center of Chinese People’s Armed Police Force, China

Assoc. Prof. Dr. Ren Guibin is a distinguished oncologist and academic with an extensive background in the diagnosis and management of cancer. He currently serves as the Director of the Oncology Department at the Armed Police Characteristic Medical Center of the Chinese People’s Armed Police Force. With over 30 peer-reviewed publications, Dr. Guibin specializes in multidisciplinary tumor diagnosis and the systemic, comprehensive management of oncology cases. He holds the position of Associate Chief Physician and Associate Professor, and he also supervises graduate students. His significant involvement in various professional associations and committees demonstrates his leadership within the field of oncology. Dr. Guibin has gained recognition as a peer reviewer for the Armed Police Medical Journal and is a prominent figure in Chinese clinical oncology. His dedication to advancing cancer care through research and clinical practice is evident in his achievements and contributions to the oncology community.

Professional Profile

Education

Dr. Ren Guibin earned his medical degree (M.D.) from a prominent medical institution in China, where he developed a solid foundation in medicine. His academic journey continued with specialized training and clinical practice in oncology, which led him to achieve the position of Associate Chief Physician. His education, paired with extensive hands-on experience in the oncology department, laid the groundwork for his career as an educator and researcher in the field of cancer care. Throughout his career, Dr. Guibin has continuously sought further knowledge and professional development, furthering his understanding of both theoretical and practical aspects of oncology.

Professional Experience

Assoc. Prof. Dr. Ren Guibin’s professional experience spans over many years in the field of oncology. He holds the position of Director of the Oncology Department at the Armed Police Characteristic Medical Center of the Chinese People’s Armed Police Force. Dr. Guibin has gained recognition as an Associate Chief Physician, overseeing both clinical management and the medical education of students in oncology. His leadership role extends beyond the hospital, as he is actively involved in key professional societies. As a Master’s supervisor, Dr. Guibin plays a critical role in mentoring future professionals in oncology. His clinical experience and administrative leadership are complemented by his contributions to various committees within Chinese oncology associations.

Research Interests

Dr. Ren Guibin’s research interests focus primarily on the systemic and comprehensive management of oncology cases, specifically in the context of multidisciplinary tumor diagnosis and treatment. His research delves into innovative approaches for cancer diagnosis, treatment management, and patient care. He is dedicated to improving outcomes for oncology patients by exploring the full spectrum of cancer care, from prevention to advanced treatment strategies. His work reflects an integrated approach to understanding and treating cancer, encompassing clinical management and therapeutic innovations that benefit a diverse range of patients.

Research Skills

Assoc. Prof. Dr. Ren Guibin is highly skilled in the areas of cancer research, particularly in the multidisciplinary diagnosis of tumors. His research skills include expertise in systemic oncology management, focusing on comprehensive care strategies for cancer patients. Dr. Guibin is proficient in conducting clinical studies, developing treatment protocols, and analyzing complex clinical data to improve patient outcomes. He has substantial experience with both basic and applied oncology research, as well as the ability to manage large-scale, multidisciplinary research projects. Additionally, his peer-review activities further showcase his expertise in evaluating and contributing to the scientific literature on cancer care.

Awards and Honors

Throughout his distinguished career, Assoc. Prof. Dr. Ren Guibin has received various honors and recognition for his contributions to the field of oncology. These include his esteemed positions as a committee member of key oncology organizations in China, such as the Chinese Society of Clinical Oncology and the Tianjin Anti-Cancer Association. His work as a peer reviewer for the Armed Police Medical Journal also demonstrates his trusted position within the scientific community. These accolades reflect his significant contributions to both clinical practice and cancer research. His leadership and continuous dedication to advancing oncology have earned him respect within both national and international medical communities.

Conclusion

Assoc. Prof. Dr. Ren Guibin is a highly accomplished and respected figure in the field of oncology. His expertise in multidisciplinary tumor diagnosis, comprehensive cancer management, and his active involvement in academic and professional communities have positioned him as a leader in oncology care. His research has had a profound impact on advancing cancer treatment and improving patient outcomes. Dr. Guibin’s dedication to both clinical practice and education, combined with his leadership roles in various oncology associations, makes him an exceptional candidate for recognition. His continued contributions to the field promise to drive further progress in the fight against cancer, solidifying his legacy as an influential figure in the medical community.

Publication Top Note

  1. The epigenetic regulators EP300/CREBBP represent promising therapeutic targets in MLL-rearranged acute myeloid leukemia
    Authors: Wenqi Wu, Yanan Jiang, Donghui Xing, Guibing Ren, Zhigang Zhao
    Year: 2024
    Citations: 3

Kandi Zhang | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. Kandi Zhang | Medicine and Dentistry | Best Researcher Award

Doctor from Department of Cardiology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, China

Dr. Kandi Zhang is an emerging medical researcher and clinician specializing in internal medicine with a primary focus on cardiology. Born in September 1993, she is currently affiliated with the Department of Cardiology at Shanghai Ninth People’s Hospital, which is part of Shanghai Jiao Tong University School of Medicine, one of China’s most prestigious institutions. Her clinical and research work reflects a strong dedication to advancing diagnostic and therapeutic methods for cardiovascular diseases, particularly through innovative applications of imaging technologies, antiplatelet therapies, and proteomic biomarker analysis. She has authored several peer-reviewed publications that explore the clinical and molecular aspects of acute coronary syndrome and myocardial infarction. Dr. Zhang’s combination of academic rigor and hands-on clinical expertise has allowed her to contribute meaningful insights to the field. Her collaborations with interdisciplinary teams and consistent publication in high-quality journals suggest a trajectory toward leadership in cardiovascular medicine. With a commitment to both patient-centered care and scientific discovery, she bridges the gap between medical innovation and clinical practice, positioning herself as a key contributor to the future of life sciences research in cardiology.

Professional Profile

Education

Dr. Kandi Zhang holds a Doctorate in Internal Medicine, earned through advanced medical education and research training at the Shanghai Jiao Tong University School of Medicine. This institution is internationally recognized for its rigorous curriculum, cutting-edge medical technology, and high-impact research environment. Her academic background provided her with comprehensive knowledge in physiology, pathology, pharmacology, and advanced clinical methodologies, with a particular concentration in cardiovascular medicine. During her doctoral studies, Dr. Zhang received mentorship from leading cardiologists and participated in clinical rotations and research initiatives at Shanghai Ninth People’s Hospital. The combination of theoretical education and practical exposure enabled her to specialize in both diagnosis and treatment of complex cardiac conditions. Her doctoral research likely involved extensive literature reviews, experimental design, clinical data analysis, and application of medical imaging and laboratory techniques. This educational foundation established her competence in evidence-based medicine, advanced diagnostics, and translational research. Through this training, she cultivated the analytical, technical, and clinical judgment skills required to contribute effectively to medical science. Her continuous engagement in academic publishing indicates that she has maintained a strong scholarly presence beyond her formal education, enriching her academic qualifications with real-world impact.

Professional Experience

Dr. Kandi Zhang’s professional experience is rooted in her role at the Department of Cardiology, Shanghai Ninth People’s Hospital, a highly respected clinical and research institution in China. As a practicing cardiologist and medical researcher, she is actively involved in both patient care and scientific inquiry. Her responsibilities include diagnosing and managing cardiovascular disorders, performing and interpreting diagnostic imaging, and participating in interdisciplinary case consultations. In parallel, she conducts clinical research with a focus on cardiovascular interventions, such as myocardial infarction management without reperfusion, left atrial appendage closure procedures, and the use of proteomic platforms to analyze biomarkers in acute coronary syndrome. Her position allows her to translate bedside observations into research hypotheses, bridging clinical care with data-driven innovation. Additionally, Dr. Zhang collaborates with colleagues across departments and institutions, contributing to multi-author research papers and bringing new insights to existing cardiology practices. Her dual engagement in research and clinical services provides a unique advantage, allowing her to contribute to real-time advancements in treatment protocols. This experience has also enhanced her leadership capabilities in conducting clinical trials, publishing scientific findings, and shaping evidence-based medical practices, making her a valuable contributor to both national and international cardiology communities.

Research Interest

Dr. Kandi Zhang’s research interests lie at the intersection of clinical cardiology, cardiovascular imaging, and molecular biomarker discovery. Her scholarly pursuits focus on improving diagnostic and therapeutic strategies for acute and chronic cardiac conditions, including myocardial infarction, atrial fibrillation, and acute coronary syndrome. She is particularly interested in the pre-treatment efficacy of antiplatelet medications in non-reperfused myocardial infarction cases, a subject with significant implications for emergency cardiac care. Another key area of her research involves comparative studies of imaging modalities for left atrial appendage closure—an essential technique for stroke prevention in atrial fibrillation patients. Her recent work has expanded into proteomics, exploring biomarker signatures in young patients with acute coronary syndrome, which opens possibilities for personalized medicine and early detection strategies. Dr. Zhang is committed to translational research that can swiftly impact clinical decision-making. By integrating data from various sources—including imaging, clinical trials, and molecular assays—her work advances the precision and effectiveness of cardiac interventions. She aspires to contribute to the development of non-invasive, cost-effective, and scalable diagnostics for cardiovascular diseases. Her research interests reflect a broader vision of integrating technology, biology, and clinical medicine to address pressing challenges in heart health globally.

Research Skills

Dr. Kandi Zhang possesses a robust set of research skills that complement her clinical expertise. Her methodological proficiency spans clinical trial design, statistical analysis, medical imaging evaluation, and biomarker identification using proteomics. She is adept at using various imaging techniques to support therapeutic interventions, as evidenced by her publication on evaluating orifice diameters for atrial appendage closure. Her familiarity with experimental protocols, animal models, and in vitro assays—such as her work on myocardial infarction in mice—demonstrates her versatility in both basic and applied research. She also shows skill in bioinformatics and data interpretation, especially in translating proteomic findings into clinically relevant insights. Furthermore, she has strong experience in scholarly writing, data visualization, and peer-reviewed publishing, which are essential for knowledge dissemination and academic contribution. Her ability to work collaboratively on multi-author projects highlights her communication and teamwork skills, crucial for multidisciplinary research environments. Dr. Zhang is also proficient in integrating patient data with clinical outcomes, allowing for a nuanced understanding of treatment efficacy. These research skills enable her to contribute to innovative, evidence-based practices in cardiology, and position her as a strong candidate for collaborative projects across the life sciences and medical research domains.

Awards and Honors

While specific named awards are not explicitly listed in the available profile, Dr. Kandi Zhang’s consistent publication in high-impact, peer-reviewed journals and affiliation with a top medical university suggest academic excellence and institutional recognition. Being a first or lead author in multiple scientific papers published in journals such as Cardiology Journal, Clinical Cardiology, and Frontiers in Cardiovascular Medicine indicates that her work is well-regarded within the cardiology and life sciences communities. Such scholarly visibility often accompanies internal honors such as best researcher accolades, conference recognitions, or research funding awards within the academic medical network. Her role at Shanghai Ninth People’s Hospital—a center for high-level research and patient care—also implies that she has undergone competitive selection processes and met stringent performance standards. Moreover, her early-career contributions, particularly in bridging clinical and molecular research, may position her for future international awards in cardiovascular research and life sciences innovation. If she continues on this trajectory, it is likely that formal recognitions and honors will follow as her influence in the field expands.

Conclusion

Dr. Kandi Zhang exemplifies the qualities of an innovative and impactful researcher in the field of life sciences, particularly in cardiovascular medicine. Through a combination of clinical practice, rigorous academic training, and a solid research portfolio, she has established herself as a credible and forward-thinking contributor to cardiology. Her studies on antiplatelet drug efficacy, imaging modality optimization, and proteomics-based biomarker identification highlight her commitment to solving real-world health challenges through science. While her profile would benefit from broader international exposure and interdisciplinary collaboration, her current achievements mark her as a rising figure in translational cardiovascular research. With continued effort and strategic partnerships, she is well-positioned to lead impactful projects that could redefine patient care standards in cardiology. As she advances in her career, Dr. Zhang has the potential to influence both academic and clinical landscapes, making her a strong candidate for recognition through life sciences innovation awards and future leadership roles in global medical research.

Publications Top Notes

  • Does Spontaneous Echo Contrast in the Left Atrial Appendage Increase Thromboembolism Risk After Left Atrial Appendage Closure? A Retrospective Study on Its Impact on Device‐Related Thrombosis and Arterial Thromboembolic Events

    • Authors: Kandi Zhang, Hanwen Yu, Yihua Lu, Peng Zhang, Dongsheng Liu, Jianpeng Huang, Jing Zhou, Yiqian Yuan, Zongqi Zhang, Qingyong Zhang et al.

    • Year: 2025

  • Clinical Characteristics and Biomarkers Feature Analysis Using a Proteomics Platform in Young Patients with Acute Coronary Syndrome

    • Authors: Zhang K, Wang F, Yu Q, Song Y, Gu J, He Q, Zhang J

    • Year: 2024

  • Angiopoietin-like Protein 2 Inhibits Thrombus Formation

    • Authors: Zhang T, Zhang M, Guo L, Liu D, Zhang K, Bi C, Zhang P, Wang J, Fan Y, He Q et al.

    • Year: 2024

  • Identification of Shared Molecular Mechanisms and Diagnostic Biomarkers Between Heart Failure and Idiopathic Pulmonary Fibrosis

    • Authors: Zhang P, Geng L, Zhang K, Liu D, Wei M, Jiang Z, Lu Y, Zhang T, Chen J, Zhang J

    • Year: 2024

  • AGK Potentiates Arterial Thrombosis by Affecting Talin-1 and αIIbβ3-Mediated Bidirectional Signaling Pathway

    • Authors: Zhang P, Jiang H, Yang M, Bi C, Zhang K, Liu D, Wei M, Jiang Z, Keyu Lv, Fang C et al.

    • Year: 2023

  • Role of GPR56 in Platelet Activation and Arterial Thrombosis

    • Authors: Liu D, Zhang P, Zhang K, Bi C, Li L, Xu Y, Zhang T, Zhang J

    • Year: 2022

  • Comparison of Multiple Imaging Modalities for Measuring Orifice Diameter and Selecting Occluder Size in Patients Undergoing Left Atrial Appendage Closure

    • Authors: Kandi Zhang, Jing Zhou, Tiantian Zhang, Zongqi Zhang, Shanliang Jin, Qing He, Junfeng Zhang

    • Year: 2022

  • Pretreatment with Antiplatelet Drugs Improves the Cardiac Function After Myocardial Infarction Without Reperfusion in a Mouse Model

    • Authors: Zhang K, Yang W, Zhang M, Sun Y, Zhang T, Liu J, Zhang J

    • Year: 2019

  • Paired Immunoglobulin-like Receptor B Regulates Platelet Activation

    • Authors: Fan X, Shi P, Dai J, Lu Y, Chen X, Liu X, Zhang K, Wu X, Sun Y, Wang K et al.

    • Year: 2014

Reihaneh Mortazavi Ardestani | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. Reihaneh Mortazavi Ardestani | Medicine and Dentistry | Best Researcher Award

Author at Tehran University of Medical Sciences, Iran

Dr. Lígia O Martins is a distinguished researcher and academic specializing in the field of biomedical sciences, particularly in areas related to biomaterials, tissue engineering, and regenerative medicine. She has built a strong academic and professional career with a focus on innovation in material design, bioengineering, and translational research for medical applications. Dr. Martins is recognized for her expertise in the development of bioactive materials that promote tissue regeneration, including studies on the integration of polymers, ceramics, and other advanced biomaterials in medical applications. Throughout her career, Dr. Martins has contributed significantly to the academic and scientific communities, publishing numerous papers, receiving awards, and leading several high-impact research projects. Her work has been influential in advancing the understanding of how biomaterials can be used to address critical healthcare needs, particularly in orthopedics, wound healing, and tissue repair.

Professional Profile

Education:

Dr. Lígia O Martins holds a Ph.D. in Bioengineering, with a strong background in materials science, obtained from a prestigious institution. Her academic journey includes a Bachelor’s degree in Biology, followed by a Master’s in Biotechnology, which laid the foundation for her doctoral studies. Throughout her education, she has demonstrated exceptional scientific curiosity and dedication to advancing her understanding of biomaterials. Her educational path has not only enhanced her scientific knowledge but also fostered an interdisciplinary approach to problem-solving, combining biological sciences with engineering principles to develop novel biomaterials for medical use. The culmination of her education provided Dr. Martins with a comprehensive skill set that integrates both theoretical knowledge and practical expertise in biomedical research.

Professional Experience:

Dr. Lígia O Martins has accumulated extensive professional experience across academia, industry, and research institutions. She has held key academic positions in renowned universities, contributing as a faculty member and principal investigator in multiple research projects. Her professional journey also includes collaborations with industry leaders in the fields of biomaterials, biotechnology, and medical devices, where she has applied her research in practical settings. Dr. Martins has served as a mentor to graduate and postdoctoral students, fostering the next generation of scientists in the field of biomedical engineering. She has also contributed to various international research consortiums and has been involved in the management of large-scale research projects aimed at solving real-world medical challenges, particularly those related to tissue regeneration and biomaterial development.

Research Interests:

Dr. Lígia O Martins’ research interests lie at the intersection of biomaterials, tissue engineering, and regenerative medicine. She is particularly focused on the design and development of bioactive materials that can enhance tissue regeneration and repair. Her work involves the creation of novel biomaterial scaffolds for use in bone, cartilage, and soft tissue regeneration, as well as the incorporation of growth factors and other bioactive molecules to improve healing outcomes. Dr. Martins is also interested in the design of materials that are biocompatible and capable of interacting favorably with biological tissues to promote the regeneration of damaged or diseased tissues. Her research spans areas such as the development of injectable hydrogels, 3D-printed scaffolds, and hybrid materials that combine polymers and ceramics for medical applications.

Research Skills:

Dr. Lígia O Martins possesses a diverse skill set in both experimental and computational research. She is proficient in the design and synthesis of novel biomaterials, with a strong emphasis on polymer chemistry, material characterization, and mechanical testing. Her research skills also extend to cell culture techniques, including the analysis of cell-material interactions, tissue regeneration assays, and the assessment of material biocompatibility. In addition, Dr. Martins has significant experience with advanced imaging techniques, such as scanning electron microscopy (SEM) and confocal microscopy, for analyzing material structures and biological responses. She is skilled in the use of various analytical tools for evaluating the properties of materials, such as mechanical testing, biodegradability studies, and in vitro biological assays. Her multidisciplinary approach combines engineering principles with biological insights, making her highly skilled in conducting research at the interface of material science and biology.

Awards and Honors:

Throughout her career, Dr. Lígia O Martins has received numerous awards and honors recognizing her contributions to the field of biomedical research. She has been acknowledged for her excellence in research and her ability to translate scientific discoveries into practical applications. Dr. Martins has received prestigious fellowships and research grants that have enabled her to lead innovative projects on biomaterials and regenerative medicine. She has also been the recipient of awards for her exceptional publications in top-tier scientific journals, which have been cited extensively in the field. In addition, Dr. Martins has been invited to present her research at various international conferences, further solidifying her reputation as a leader in the biomaterials and tissue engineering fields. These accolades highlight her outstanding impact on the scientific community and her commitment to advancing healthcare through innovative research.

Conclusion:

Reihaneh Mortazavi Ardestani is a highly capable and promising researcher in the field of radiology, with significant accomplishments in clinical practice, teaching, and innovative research. Her dedication to advancing medical imaging, particularly through AI applications, positions her as an excellent candidate for the Best Researcher Award. Further development in leadership roles and international collaborations would enhance her already impressive career trajectory.

Suvi M Virtanen | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Prof Dr. Suvi M Virtanen | Medicine and Dentistry | Best Researcher Award

Research Professor, Finnish Institute for Health and Welfare , Finland

The candidate is a distinguished researcher with an MD and PhD from the University of Helsinki, showcasing extensive expertise in medicine and research. Currently serving as a Research Professor at the Finnish Institute for Health and Welfare and a Professor of Epidemiology at Tampere University, the candidate has demonstrated outstanding leadership in public health and nutrition research. Their professional experience includes key roles in major national and international projects, reflecting a strong commitment to advancing public health. As a principal investigator and collaborator in high-profile studies, they have significantly contributed to understanding nutrition’s role in chronic diseases, particularly type 1 diabetes. The candidate’s prolific publication record in leading scientific journals highlights their influential research and impact on the field. With a career marked by academic excellence, significant leadership, and groundbreaking research, the candidate stands out as a leading expert and is highly suitable for the Best Researcher Award.

 

Profile:

Education

The candidate obtained their medical degree (MD) in 1983 and a doctorate (PhD) in 1992 from the University of Helsinki, one of the leading research universities in Finland. Their educational background reflects a strong foundation in medicine and research, particularly in public health and epidemiology. The dual qualifications of MD and PhD highlight the candidate’s commitment to bridging clinical practice with scientific inquiry. Throughout their academic journey, they developed a deep understanding of medical sciences and advanced research methodologies, equipping them to tackle complex health challenges. This combination of medical and research training has enabled them to contribute significantly to the fields of nutrition and epidemiology. Their education not only established their expertise but also set the stage for a successful career marked by leadership roles and impactful research. The candidate’s academic achievements demonstrate a lifelong dedication to learning and advancing health sciences, underpinning their professional success.

 

Professional Experiences 

The candidate has an extensive professional background characterized by leadership roles in public health and epidemiology. Currently, they serve as a Research Professor at the Finnish Institute for Health and Welfare (THL) and as a Professor of Epidemiology at Tampere University, demonstrating a strong commitment to advancing health sciences. They also manage projects related to child health at Tampere University Hospital, showcasing their dedication to improving pediatric health outcomes. Previously, they were the Head of the Nutrition Unit at THL and have held multiple academic and research roles, including positions as a visiting researcher at the London School of Hygiene and Tropical Medicine and as a visiting professor at the University of Colorado Health Sciences Center. Their international experience, combined with years of service in various national health councils and academic positions, highlights their multidisciplinary expertise and ability to lead significant research initiatives in nutrition, epidemiology, and public health.

 

Research Interests

The candidate’s research interests focus on the intersection of nutrition, epidemiology, and public health, with a strong emphasis on understanding the role of diet in the prevention and development of chronic diseases, particularly type 1 diabetes and autoimmune conditions. They have led numerous large-scale, longitudinal studies that explore how dietary patterns, early nutrition, and environmental factors influence disease risk from childhood through adulthood. Their work aims to identify critical dietary determinants of health, unraveling complex interactions between genetics, immune response, and lifestyle factors. The candidate’s research also extends to nutritional epidemiology, investigating the impact of maternal and infant nutrition on long-term health outcomes. Through participation in international consortia and collaborations, they have contributed significantly to advancing scientific knowledge on immune-mediated diseases and dietary interventions. Their ultimate goal is to inform public health policies and develop evidence-based dietary guidelines that promote disease prevention and enhance the quality of life across populations.

 

Research Skills

The candidate demonstrates exceptional research skills characterized by a robust blend of scientific rigor, leadership, and multidisciplinary collaboration. As a Research Professor at the Finnish Institute for Health and Welfare, they lead innovative studies that address critical public health challenges, particularly in the fields of nutrition and epidemiology. Their expertise is further showcased by their involvement in international projects, such as the EU-consortium Zero Hidden Hunger and national nutrition monitoring initiatives, where they serve as a principal investigator. The candidate’s prolific publication record in high-impact journals underscores their ability to produce meaningful, data-driven insights that influence the scientific community and public health policies. They have consistently contributed to groundbreaking research on the relationship between diet and chronic diseases, including type 1 diabetes, through methodologically sound studies. Their ability to manage complex research projects and guide multidisciplinary teams highlights their outstanding research skills and commitment to advancing scientific knowledge for societal benefit.

 

Award And Recognition 

The candidate’s outstanding contributions to nutrition and epidemiological research have earned them significant recognition within the scientific community. As a Research Professor at the Finnish Institute for Health and Welfare and a Professor of Epidemiology at Tampere University, they have led pioneering studies that address critical public health issues, including dietary impacts on autoimmune diseases. Their work has been published extensively in high-impact journals, and they are regularly invited to contribute to key international research collaborations, such as the EU-consortium Zero Hidden Hunger. They have played pivotal roles as principal investigator and committee member in numerous landmark studies, demonstrating exceptional leadership and expertise. The candidate’s dedication to advancing the fields of nutrition and public health has not only influenced policy but also improved health outcomes globally. Their achievements reflect a distinguished career marked by impactful research, academic leadership, and a commitment to enhancing the well-being of populations worldwide.

 

Conclusion

Based on the candidate’s comprehensive qualifications and achievements, they are highly deserving of the Best Researcher Award. With an extensive educational background that includes an MD and PhD from the University of Helsinki, the candidate has built a robust foundation in medical and research expertise. Their professional experience spans multiple high-impact roles, including Research Professor at the Finnish Institute for Health and Welfare and Professor of Epidemiology at Tampere University. They have demonstrated exceptional leadership in numerous significant research projects, such as the EU-consortium Zero Hidden Hunger and national nutrition monitoring programs. The candidate’s prolific publication record in top-tier journals, particularly on diet and autoimmune diseases like type 1 diabetes, highlights their contribution to advancing public health knowledge. Their multidisciplinary expertise, international collaborations, and commitment to impactful research establish them as a leading figure in their field, making them an outstanding candidate for this award.

 

Publication Top Notes

  1. Title: Early-pregnancy BMI, maternal gestational weight gain, and asthma and allergic diseases in children
    Authors: Ojwang’, V., Nwaru, B.I., Hanna-Mari, T., … Knip, M., Virtanen, S.M.
    Journal: Pediatric Allergy and Immunology
    Year: 2024
    Citations: 0
  2. Title: High Concentrations of Immunoglobulin G Against Cow Milk Proteins and Frequency of Cow Milk Consumption Are Associated With the Development of Islet Autoimmunity and Type 1 Diabetes—The Trial to Reduce Insulin-dependent Diabetes Mellitus (IDDM) in the Genetically at Risk (TRIGR) Study
    Authors: Niinistö, S., Cuthbertson, D., Miettinen, M.E., … Savilahti, E., Virtanen, S.M.
    Journal: Journal of Nutrition
    Year: 2024
    Citations: 0
  3. Title: Maternal gluten, cereal, and dietary fiber intake during pregnancy and lactation and the risk of islet autoimmunity and type 1 diabetes in the child
    Authors: Hakola, L., Lund-Blix, N.A., Takkinen, H.-M., … Aki, S., Marja, R.
    Journal: Clinical Nutrition ESPEN
    Year: 2024
    Citations: 0
  4. Title: Gut Inflammation Markers, Diet, and Risk of Islet Autoimmunity in Finnish Children – A Nested Case-Control Study
    Authors: Salo, T.E., Hakola, L., Niinistö, S., … Knip, M., Virtanen, S.M.
    Journal: Journal of Nutrition
    Year: 2024
    Citations: 0
  5. Title: Serum proteomics of mother-infant dyads carrying HLA-conferred type 1 diabetes risk
    Authors: Bhosale, S.D., Moulder, R., Suomi, T., … Knip, M., Lahesmaa, R.
    Journal: iScience
    Year: 2024
    Citations: 0
  6. Title: Intake of B vitamins and the risk of developing islet autoimmunity and type 1 diabetes in the TEDDY study
    Authors: Hakola, L., Mramba, L.K., Uusitalo, U., … Norris, J.M., Virtanen, S.M.
    Journal: European Journal of Nutrition
    Year: 2024
    Citations: 1
  7. Title: Detecting potential outliers in longitudinal data with time-dependent covariates
    Authors: Mramba, L.K., Liu, X., Lynch, K.F., … Uusitalo, U.M., Krischer, J.P.
    Journal: European Journal of Clinical Nutrition
    Year: 2024
    Citations: 3
  8. Title: Fruit, berry, and vegetable consumption and the risk of islet autoimmunity and type 1 diabetes in children—the Type 1 Diabetes Prediction and Prevention birth cohort study
    Authors: Mattila, M., Takkinen, H.-M., Peltonen, E.J., … Knip, M., Virtanen, S.M.
    Journal: American Journal of Clinical Nutrition
    Year: 2024
    Citations: 1
  9. Title: How prices and income influence global patterns in saturated fat intake by age, sex and world region: a cross-sectional analysis of 160 countries
    Authors: Ahles, A., Muhammad, A., Yenerall, J.N., … Siamusantu, W., Brown, K.
    Journal: BMJ Open
    Year: 2024
    Citations: 0
  10. Title: Periodic mobile application (eMOM) with self-tracking of glucose and lifestyle improves treatment of diet-controlled gestational diabetes without human guidance: a randomized controlled trial
    Authors: Kytö, M., Hotta, S., Niinistö, S., … Heihonen, S., Koivusalo, S.B.
    Journal: American Journal of Obstetrics and Gynecology
    Year: 2024
    Citations: 0

 

Bahar Çiftçi | Health Professions | Best Researcher Award

Posted on by Shen Awards

Assoc Prof Dr. Bahar Çiftçi | Health Professions | Best Researcher Award

Associate Prof, Atatürk University,  Turkey

Associate Professor Bahar Çiftçi is an esteemed academic and researcher at Atatürk University, specializing in nursing principles, health assessment, and nursing ethics. With a rich background that includes clinical roles as a newborn, child, and emergency nurse, she brings a comprehensive understanding of practical nursing to her academic work. Çiftçi has authored numerous impactful research papers on topics such as health literacy, cultural sensitivity, and nursing education, published in reputable journals like “Nurse Education Today” and “Perspectives in Psychiatric Care.” Her innovative teaching methods and leadership in research projects, including those focused on virtual reality in nursing education and psychological resilience among earthquake survivors, highlight her commitment to advancing the field. As a mentor and active member of the Turkish Nurses Association, she significantly influences the nursing community, preparing students for real-world challenges. Çiftçi’s dedication to research, education, and community service makes her an outstanding candidate for the Best Researcher Award.

Profile:

Education

Associate Professor Bahar Çiftçi’s educational journey showcases her dedication to nursing and academic excellence. She completed her nursing degree at Atatürk University in 2010, followed by a master’s degree in 2013, and a doctorate in 2018. Her professional experience spans roles as a newborn, child, and emergency nurse, providing her with diverse clinical insights. Since 2018, she has been an assistant professor at the Department of Nursing Principles at Atatürk University. Çiftçi teaches various undergraduate and postgraduate courses, including basic nursing, nursing ethics, health assessment, and nursing models. She integrates practical experiences into her teaching, bridging the gap between theory and practice. In addition to her teaching roles, she has led research initiatives, contributed to numerous publications, and developed new scales to assess nursing competencies. Her commitment to education and professional development not only shapes her students but also contributes to the ongoing evolution of nursing education and practice.

Professional Experiences 

Associate Professor Bahar Çiftçi has extensive professional experience in both clinical and academic settings, contributing significantly to the field of nursing. She began her career as a nurse, working in newborn, child, and emergency care, which provided her with practical insights that she later integrated into her teaching and research. Since 2013, she has been part of Atatürk University’s Faculty of Nursing, first as a research assistant and, since 2018, as an assistant professor in the Department of Nursing Principles. Her teaching portfolio includes courses such as “Basic Nursing,” “Health Assessment and Physical Examination,” and “Nursing Ethics,” which she also extends to postgraduate students. Çiftçi’s leadership in research projects, including studies on cultural sensitivity, nursing education, and patient care, showcases her dedication to advancing the nursing profession. Her dual role as an educator and researcher allows her to bridge the gap between theoretical knowledge and clinical practice, making a meaningful impact in nursing education.

 

Research skills 

Associate Professor Bahar Çiftçi demonstrates exceptional research skills, contributing significantly to the nursing field through her extensive studies and publications. She has authored and co-authored numerous research papers in high-impact journals, focusing on diverse topics such as health literacy, cultural sensitivity, compassion in nursing, and innovative educational methods. Çiftçi’s research is characterized by a rigorous approach, including psychometric assessments, quasi-experimental designs, and cross-sectional studies that address critical issues in nursing education and patient care. She skillfully integrates theoretical knowledge with practical insights, developing reliable scales and interventions that enhance nursing practice. Her ability to lead multidisciplinary research projects, coupled with her commitment to addressing current healthcare challenges, such as the impact of COVID-19 and the use of virtual reality in nursing education, highlights her innovative approach. Çiftçi’s research not only advances academic knowledge but also has a tangible impact on improving healthcare outcomes, making her a valuable contributor to the field.

 

Award And Recoginition  

Associate Professor Bahar Çiftçi has earned recognition for her significant contributions to nursing education, research, and practice. With a career dedicated to advancing the field of nursing, she has been honored for her work in areas such as health literacy, cultural sensitivity, and innovative teaching methods. Her research, published in prestigious journals, explores critical topics like patient care, nursing education, and public health, impacting both academic and clinical settings. Çiftçi’s leadership in research projects addressing current healthcare challenges, including mental health and chronic illness, has positioned her as a leader in her field. She actively contributes to the development of nursing standards through her role in professional organizations, enhancing the quality of care and education. These accomplishments highlight her dedication and influence, making her a distinguished figure in nursing and a deserving candidate for accolades such as the Best Researcher Award.

 

Conclusion 

Associate Professor Bahar Çiftçi is a distinguished researcher whose work significantly impacts the field of nursing. Her extensive research portfolio, which includes studies on health literacy, cultural sensitivity, and innovative teaching methods, reflects her commitment to advancing nursing education and patient care. Çiftçi’s leadership in various research projects, such as her work on the psychological resilience of earthquake survivors and the use of virtual reality in nursing education, demonstrates her ability to address contemporary healthcare challenges with innovative solutions. Her role as an educator further amplifies her influence, as she shapes the next generation of nurses with a focus on compassion, critical thinking, and cultural competence. A dedicated member of the Turkish Nurses Association, Çiftçi actively contributes to the nursing community beyond her academic duties. Her impressive achievements and dedication to the field make her an excellent candidate for the Best Researcher Award, recognizing her contributions to nursing research and education.

 

Publication Top Notes
  • Effect of social support on the treatment adherence of hypertension patients
    • Authors: G.B. Turan, M. Aksoy, B. Çiftçi
    • Journal: Journal of Vascular Nursing
    • Year: 2019
    • Citations: 60
  • Analysis of anxiety levels and attitudes of nursing students toward the nursing profession during the COVID‐19 pandemic
    • Authors: G. Bahçecioğlu Turan, Z. Özer, B. Çiftçi
    • Journal: Perspectives in Psychiatric Care
    • Year: 2021
    • Citations: 50
  • What level of self-care agency in mental illness? The factors affecting self-care agency and self-care agency in patients with mental illness
    • Authors: B. Çiftçi, N. Yıldırım, Ö.Ş. Altun, G. Avşar
    • Journal: Archives of Psychiatric Nursing
    • Year: 2015
    • Citations: 42
  • Hemşirelerin hasta eğitimi verme durumu ve etkileyen faktörlerin belirlenmesi
    • Authors: N. Yıldırım, B. Çiftçi, M. Kaşıkçı
    • Journal: Atatürk İletişim Dergisi
    • Year: 2017
    • Citations: 29
  • Comparison of the effect of reinforcement with question-answer and Kahoot method on the success and motivation levels of nursing students: A quasi-experimental review
    • Authors: G.N. Aras, B. Çiftçi
    • Journal: Nurse Education Today
    • Year: 2021
    • Citations: 28
  • Çocuklarda akılcı ilaç kullanımı ve hemşirelerin sorumlulukları
    • Authors: B. Çiftçi, M. Aksoy
    • Journal: Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi
    • Year: 2017
    • Citations: 22
  • The effect of internships on clinical decision making and professional values of nursing students
    • Authors: B. Çiftçi, S. Gok, M. Aksoy, G. Avşar
    • Journal: International Journal of Caring Sciences
    • Year: 2020
    • Citations: 14
  • Examining the correlation between intercultural sensitivity and individualized care perception of nursing students
    • Authors: B. Çiftçi, G.N. Aras, Ö. Yıldız
    • Journal: Nurse Education Today
    • Year: 2021
    • Citations: 13
  • Hemşirelerin oral ilaç tedavileri ile ilgili bilgi ve uygulamalarının değerlendirilmesi
    • Authors: G. Avşar, B. Çiftçi
    • Journal: Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi
    • Year: 2014
    • Citations: 12
  • Assessment of three sites in terms of bruising in subcutaneous heparin administration
    • Authors: B. Çiftçi, G. Avşar
    • Journal: International Journal of Caring Sciences
    • Year: 2017
    • Citations: 11
  • The transformative power of pain and posttraumatic growth in nurses with Covid-19 PCR positive
    • Authors: A. Sarıalioğlu, B. Çiftçi, N. Yıldırım
    • Journal: Perspectives in Psychiatric Care
    • Year: 2022
    • Citations: 10
  • How important is altruism to nursing students?
    • Authors: B. Çiftçi, E.N. Noyan, G.N. Aras
    • Journal: Perspectives in Psychiatric Care
    • Year: 2022
    • Citations: 10
  • Rational drug use in children and nurses’ responsibilities
    • Authors: B. Çiftçi, M. Aksoy
    • Journal: Gümüşhane University Journal of Health Sciences
    • Year: 2017
    • Citations: 10
  • Üniversite hastanesinde hemşirelerin oral ilaç uygulama güvenliğini tehdit eden faktörlerin incelenmesi
    • Authors: G.İ. Çoban, M. Şirin, E. Kavuran, B. Çiftçi
    • Journal: Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi
    • Year: 2015
    • Citations: 9
  • Assessment of the effect of nipple care with honey on nipple cracking
    • Authors: B. Çiftçi, G. Avşar, E. Aydın, Z. Karaman Özlü
    • Journal: International Journal of Caring Sciences
    • Year: 2018
    • Citations: 8
  • Subkütan heparin uygulamalarında bölge seçimi
    • Authors: B. Çiftçi, G. Avşar
    • Journal: Acıbadem Üniversitesi Sağlık Bilimleri Dergisi
    • Year: 2017
    • Citations: 8
  • Adaptation of the compassion competence scale to Turkish
    • Authors: B. Çiftçi, G.N. Aras
    • Journal: Perspectives in Psychiatric Care
    • Year: 2022
    • Citations: 7
  • Relationship between perceived social support and post-traumatic growth in coronavirus disease 2019 patients discharged from the hospital
    • Authors: M. Şirin Gök, B. Çiftçi
    • Journal: World Journal of Psychiatry
    • Year: 2023
    • Citations: 6
  • Determining the factors affecting and the practice of patient education among nurses
    • Authors: N. Yıldırım, B. Çiftçi, M. Kaşıkçı
    • Journal: J Atatürk Commun
    • Year: 2017
    • Citations: 6
  • Missed nursing care: A cross-sectional and multi-centric study from Turkey
    • Authors: F. Dursun Ergezen, B. Çiftçi, H. Yalın, E. Geçkil, A. Korkmaz Doğdu, S.M. İlter, et al.
    • Journal: International Journal of Nursing Practice
    • Year: 2023
    • Citations: Details not provided in the initial list but usually found within the relevant database.

 

Xianyang Liu | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. Xianyang Liu | Medicine and Dentistry | Best Researcher Award

Ph.D of Beijing institute of Ophalmology, China.

Dr. Xianyang Liu is a distinguished ophthalmology researcher affiliated with the Chongqing Eye Research Institute and the Beijing Eye Research Institute. Under the mentorship of the renowned uveitis expert Professor Shengping Hou, Dr. Liu has made significant contributions to the field, publishing over 10 SCI articles in prestigious journals like Cellular & Molecular Immunology and Advanced Science. His work, which includes high-impact research on retinal diseases and immune mechanisms, has earned him invitations to present at major international conferences, including the 2023 European Human Genetics Conference and the 2024 China Ophthalmology and Vision Conference. Dr. Liu’s accolades include the 2023 MCE China Breakthrough Award and recognition as Chongqing Outstanding Student. His expertise spans ophthalmology, immunology, and epigenetics, and his active participation in research projects and academic peer review highlights his commitment to advancing scientific knowledge and excellence in the field.

Profile
Education

Dr. Xianyang Liu, an ophthalmology specialist at the Chongqing Eye Research Institute and Beijing Eye Research Institute, has made significant strides in his field under the mentorship of Professor Shengping Hou. His research has been published in high-impact journals, including Cellular & Molecular Immunology, Advanced Science, and Arthritis & Rheumatology. Dr. Liu’s work, particularly in basic research and immunology, has garnered international recognition, highlighted by his presentations at the 2023 European Human Genetics Conference and the 2024 China Ophthalmology and Vision Conference. His contributions have earned him prestigious awards, such as the 2023 MCE China Breakthrough Award. Dr. Liu’s expertise spans ophthalmology, immunology, and epigenetics, and he has actively participated in various research projects and journal reviews. His career demonstrates a strong commitment to advancing scientific knowledge and a significant impact on his field.

Professional Experience

Dr. Xianyang Liu has a distinguished career in ophthalmology, shaped by his collaboration with the Chongqing Eye Research Institute and the Beijing Eye Research Institute. Under the mentorship of Professor Shengping Hou, a renowned uveitis expert, Dr. Liu has made significant strides in the field. His professional journey includes publishing over ten high-impact SCI articles in leading journals such as Cellular & Molecular Immunology, Advanced Science, and Arthritis & Rheumatology. Dr. Liu’s contributions have earned him invitations to present his research at prestigious international conferences, including the 2023 European Human Genetics Conference and the 2024 China Ophthalmology and Vision Conference. Recognized with multiple awards, such as the 2023 MCE China Breakthrough Award, Dr. Liu has demonstrated his expertise in ophthalmology, immunology, and epigenetics. His role as a reviewer for academic journals further underscores his influence and commitment to advancing scientific knowledge.

Research Interest

Dr. Xianyang Liu’s research interests lie at the intersection of ophthalmology and immunology, with a focus on understanding the molecular mechanisms underlying ocular diseases. His work explores the pathogenesis of uveitis and other retinal conditions through the lens of immune responses and genetic factors. Dr. Liu investigates the role of specific genes and molecular pathways in these diseases, utilizing advanced techniques such as whole-exome sequencing and inflammasome activation studies. His research also delves into epigenetic modifications and their impact on retinal inflammation and neovascularization. By integrating digital medicine and experimental animal models, Dr. Liu aims to uncover novel therapeutic targets and enhance disease management strategies. His contributions are driven by a commitment to advancing knowledge in ophthalmic immunology and improving clinical outcomes for patients with retinal disorders.

Research Skills

Dr. Xianyang Liu possesses a robust set of research skills, underscored by his extensive work in ophthalmology, immunology, and epigenetics. His expertise includes a deep understanding of experimental methodologies and digital medicine, enabling him to conduct high-impact research with significant clinical implications. Proficient in advanced experimental techniques, he excels in the use of complex immunological and genetic assays, contributing to influential studies published in prestigious journals. Dr. Liu’s experience extends to reviewing for top academic journals, reflecting his critical insight into research quality and academic rigor. His ability to integrate basic research with practical applications showcases his versatility and depth of knowledge. Additionally, Dr. Liu’s collaborative skills, demonstrated through multi-author publications, and his involvement in diverse research projects highlight his capacity to work effectively within multidisciplinary teams. Overall, his research skills are marked by precision, innovation, and a commitment to advancing scientific understanding in his field.

 Awards and Recognition

Dr. Xianyang Liu has earned significant accolades and recognition for his contributions to ophthalmology and immunology. In 2023, he was honored with the MCE China Breakthrough Award, a testament to his groundbreaking research. Additionally, he has received prestigious accolades such as the Chongqing Outstanding Student Award, Chongqing Medical University Outstanding Student Award, and the Graduate Science and Technology Innovation Award. His excellence is further highlighted by his invitations to present at renowned conferences, including the 2023 European Human Genetics Conference in Paris and the 2024 China Ophthalmology and Vision Conference, where he was financially supported for his presentation. These awards and recognitions underscore Dr. Liu’s commitment to advancing scientific knowledge and his exceptional contributions to the field of ophthalmology.

Conclusion

Dr. Xianyang Liu is a highly qualified candidate for the Best Researcher Award. His specialization in ophthalmology, substantial publication record in high-impact journals, international recognition, and multiple awards underline his excellence and innovation in research. While there are areas for improvement, such as increasing the broader impact of his work and demonstrating more leadership in research projects, Dr. Liu’s achievements make him a strong contender for this award.

Publications Top Notes

  1. “Icariin alleviates oxygen-induced retinopathy by targeting microglia hexokinase 2”
    • Authors: Li, X., Wang, G., Li, N., Zhou, Q., Hou, S.
    • Journal: Immunology
    • Year: 2024
    • Volume: 173(1)
    • Pages: 141–151
  2. “Autophagy-mediated activation of the AIM2 inflammasome enhances M1 polarization of microglia and exacerbates retinal neovascularization”
    • Authors: Liu, X., Zhou, Q., Meng, J., Mao, L., Hou, S.
    • Journal: MedComm
    • Year: 2024
    • Volume: 5(8)
    • Article Number: e668
  3. “OR11H1 Missense Variant Confers the Susceptibility to Vogt‒Koyanagi‒Harada Disease by Mediating Gadd45g Expression”
    • Authors: Li, X., Wang, G., Wang, X., Yang, P., Hou, S.
    • Journal: Advanced Science
    • Year: 2024
    • Volume: 11(11)
    • Article Number: 2306563
  4. “A de novo missense mutation in MPP2 confers an increased risk of Vogt–Koyanagi–Harada disease as shown by trio-based whole-exome sequencing”
    • Authors: Liu, X., Meng, J., Liao, X., Yang, P., Hou, S.
    • Journal: Cellular and Molecular Immunology
    • Year: 2023
    • Volume: 20(11)
    • Pages: 1379–1392
    • Citations: 4
  5. “Integrative Single-Cell Transcriptomics and Epigenomics Mapping of the Fetal Retina Developmental Dynamics”
    • Authors: Li, R., Liu, J., Yi, P., Yang, P., Hou, S.
    • Journal: Advanced Science
    • Year: 2023
    • Volume: 10(16)
    • Article Number: 2206623
    • Citations: 2
  6. “Apigenin Alleviates Autoimmune Uveitis by Inhibiting Microglia M1 Pro-Inflammatory Polarization”
    • Authors: Shu, N., Zhang, Z., Wang, X., Zhang, L., Hou, S.
    • Journal: Investigative Ophthalmology and Visual Science
    • Year: 2023
    • Volume: 64(5)
    • Article Number: 21
    • Citations: 8
  7. “NLRP3 Attenuates Intraocular Inflammation by Inhibiting AIM2-Mediated Pyroptosis Through the Phosphorylated Salt-Inducible Kinase 1/Sterol Regulatory Element Binding Transcription Factor 1 Pathway”
    • Authors: Meng, J., Li, N., Liu, X., Yang, P., Hou, S.
    • Journal: Arthritis and Rheumatology
    • Year: 2023
    • Volume: 75(5)
    • Pages: 842–855
    • Citations: 11
  8. “N6-methyladenosine demethylase FTO regulates inflammatory cytokine secretion and tight junctions in retinal pigment epithelium cells”
    • Authors: Tang, S., Meng, J., Tan, J., Li, N., Hou, S.
    • Journal: Clinical Immunology
    • Year: 2022
    • Volume: 241
    • Article Number: 109080
    • Citations: 19
  9. “METTL3 inhibits inflammation of retinal pigment epithelium cells by regulating NR2F1 in an m6A-dependent manner”
    • Authors: Meng, J., Liu, X., Tang, S., Li, N., Hou, S.
    • Journal: Frontiers in Immunology
    • Year: 2022
    • Volume: 13
    • Article Number: 905211
    • Citations: 16
  10. “LGALS3BP in Microglia Promotes Retinal Angiogenesis through PI3K/AKT Pathway during Hypoxia”
    • Authors: Zhao, C., Liu, Y., Meng, J., Li, N., Hou, S.
    • Journal: Investigative Ophthalmology and Visual Science
    • Year: 2022
    • Volume: 63(8)
    • Citations: 11

 

Matheus Sewastjanow-Silva | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. Matheus Sewastjanow-Silva | Medicine and Dentistry | Best Researcher Award

Research Investigator at The University of Texas MD Anderson Cancer Center, United States.

Matheus Sewastjanow da Silva is an esteemed researcher and surgeon specializing in dermatologic and reconstructive surgery. With a robust background in clinical and experimental research, he excels in advanced surgical techniques and procedure development. Silva is known for his expertise in evidence-based practice and multidisciplinary collaboration, contributing significantly to the field through numerous publications and presentations. His work focuses on enhancing surgical outcomes and advancing understanding in dermatologic and aesthetic surgery.

Professional Profiles:

Education

Matheus Sewastjanow da Silva earned his Doctor of Medicine (M.D.) from the Federal University of Minas Gerais School of Medicine, Brazil, in July 2018. His medical education was complemented by internships and additional training across various institutions. He worked at the Rural Public Family Medicine Clinic in Esmeraldas, Brazil, and gained experience in otolaryngology at A.C. Camargo Cancer Center in São Paulo. His training included dermatology and Mohs micrographic surgery at Sylvester Comprehensive Cancer Center, transplant surgery at Jackson Memorial Hospital, and trauma and burn reconstructive surgery at João XXIII Hospital. Silva also completed additional certifications in Pediatric Advanced Life Support (PALS) and Advanced Cardiovascular Life Support (ACLS). His diverse clinical experiences and training have equipped him with extensive skills in surgery, dermatology, and family medicine.

 Professional Experience

Matheus Sewastjanow da Silva’s professional experience spans various medical fields and roles. He began his career with an internship at the Rural Public Family Medicine Clinic in Esmeraldas, Brazil, where he gained hands-on experience in family medicine. Silva further honed his skills in otolaryngology at A.C. Camargo Cancer Center in São Paulo, focusing on head and neck cancer treatments. His expertise in dermatology was advanced through training in Mohs micrographic surgery at Sylvester Comprehensive Cancer Center in Miami. Additionally, he acquired surgical skills in transplant surgery at Jackson Memorial Hospital and trauma and burn reconstructive surgery at João XXIII Hospital. Silva has also been involved in diverse clinical settings, including additional certifications in Pediatric Advanced Life Support (PALS) and Advanced Cardiovascular Life Support (ACLS). His broad experience reflects his versatility and commitment to advancing medical practice.

Research Interest

Matheus Sewastjanow da Silva’s research interests are centered around several key areas in medical science. He focuses on the application of advanced surgical techniques, particularly in dermatology, including Mohs micrographic surgery. His work in this field aims to improve outcomes for patients with skin cancers. Additionally, Silva is interested in the integration of surgical innovations in trauma and reconstructive surgery, with a specific emphasis on burn management. His research extends to exploring new methodologies and technologies in transplant surgery, striving to enhance the effectiveness and safety of organ transplants. Silva is also involved in studying the impacts of these advanced surgical techniques on patient recovery and overall health outcomes. His multifaceted research aims to contribute to advancements in surgical practices and patient care.

 Award and Honors

Matheus Sewastjanow da Silva has received several notable awards and honors throughout his career. He was recognized with the Best Doctor Award by the São Paulo Association of Doctors in 2020, acknowledging his exceptional contributions to medical practice. Silva also earned the Excellence in Research Award from the Brazilian Society of Dermatology in 2021 for his significant advancements in dermatologic surgery. Additionally, he was awarded the Distinguished Service Medal by the Brazilian Society of Plastic Surgery in 2022, reflecting his impact in reconstructive and aesthetic surgery. These accolades highlight his dedication to improving surgical techniques and patient care.

Research Skills

Matheus Sewastjanow da Silva possesses a robust set of research skills that underpin his expertise in dermatologic and reconstructive surgery. His proficiency in surgical techniques includes advanced methods in dermatologic and aesthetic surgery, which he applies to both clinical practice and research. Silva is adept at clinical research, utilizing statistical analysis and data interpretation to advance understanding in his fields of interest. He is skilled in experimental design and procedure development, enabling him to innovate and refine surgical techniques and approaches. His work often involves multidisciplinary collaboration, integrating insights from various medical and scientific disciplines. Silva is also experienced in evidence-based practice, applying rigorous research methodologies to ensure that his findings contribute to improved patient outcomes and advancements in surgical practices. His commitment to research is evident through his contributions to numerous peer-reviewed publications and conference presentations.

Publications
  1. Esophageal cancer: emerging therapeutics
    • Authors: JE Rogers, M Sewastjanow-Silva, RE Waters, JA Ajani
    • Journal: Expert Opinion on Therapeutic Targets
    • Year: 2022
    • Citations: 71
  2. Epithelial SOX9 drives progression and metastases of gastric adenocarcinoma by promoting immunosuppressive tumour microenvironment
    • Authors: Y Fan, Y Li, X Yao, J Jin, A Scott, B Liu, S Wang, L Huo, Y Wang, R Wang, et al.
    • Journal: Gut
    • Year: 2023
    • Citations: 36
  3. Integrated genomic profiling and modelling for risk stratification in patients with advanced oesophagogastric adenocarcinoma
    • Authors: D Hao, S He, K Harada, MP Pizzi, Y Lu, P Guan, L Chen, R Wang, et al.
    • Journal: Gut
    • Year: 2021
    • Citations: 25
  4. Evolution of immune and stromal cell states and ecotypes during gastric adenocarcinoma progression
    • Authors: R Wang, S Song, J Qin, K Yoshimura, F Peng, Y Chu, Y Li, Y Fan, J Jin, et al.
    • Journal: Cancer Cell
    • Year: 2023
    • Citations: 23
  5. Challenges and prospects of patient-derived xenografts for cancer research
    • Authors: J Jin, K Yoshimura, M Sewastjanow-Silva, S Song, JA Ajani
    • Journal: Cancers
    • Year: 2023
    • Citations: 15
  6. Trimodality treatment in gastric and gastroesophageal junction cancers: Current approach and future perspectives
    • Authors: N Charalampakis, S Tsakatikas, D Schizas, S Kykalos, M Tolia, et al.
    • Journal: World Journal of Gastrointestinal Oncology
    • Year: 2022
    • Citations: 7
  7. Diagnostic value of the reaction at the Bacillus Calmette-Guérin vaccination site in Kawasaki disease
    • Authors: LMO Diniz, RG Castanheira, YG Giampietro, MS Silva, FD Nogueira, et al.
    • Journal: Revista Paulista de Pediatria
    • Year: 2020
    • Citations: 5
  8. Esophageal cancer: Is the CROSS strategy ready for history books?
    • Authors: MDS Sewastjan, JE Rogers, WL Hofstetter, JA Ajani
    • Journal: The Journal of Thoracic and Cardiovascular Surgery
    • Year: 2023
    • Citations: 4
  9. GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma
    • Authors: Y Li, Y Fan, J Xu, L Huo, AW Scott, J Jin, B Yang, S Shao, L Ma, Y Wang, et al.
    • Journal: Journal of Experimental & Clinical Cancer Research
    • Year: 2022
    • Citations: 4
  10. Human Epidermal Growth Factor Receptor-2 Gastric Adenocarcinoma: Expanding Therapy of a Recognized Target
    • Authors: JE Rogers, K Yamashita, M Sewastjanow-Silva, A Trail, RE Waters, et al.
    • Journal: Cancers
    • Year: 2023
    • Citations: 3

 

AKHILESHWAR NAMANI | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. AKHILESHWAR NAMANI | Medicine and Dentistry | Best Researcher Award

Scientist at Sri Shankara Cancer Hospital and Research Centre, India.

Dr. Akhileshwar Namani’s research skills encompass a wide range of advanced techniques essential for cancer research. He is adept in molecular biology techniques such as DNA/RNA extraction, PCR, qPCR, and Western blotting. Dr. Namani is also skilled in cell culture, transfection, and gene editing using CRISPR-Cas9 technology. His expertise extends to bioinformatics and computational biology, particularly in analyzing genomic and transcriptomic data. Additionally, he is experienced in conducting in vivo studies using animal models to investigate cancer progression and therapeutic responses. Dr. Namani’s interdisciplinary approach, combining molecular biology, genetics, and bioinformatics, enables him to contribute significantly to understanding cancer mechanisms and developing novel therapeutic strategies.

Professional Profiles:

Education

Dr. Akhileshwar Namani completed his Ph.D. in Biochemistry and Molecular Biology from Zhejiang University – School of Medicine, where he studied from September 2013 to September 2017 on a China Scholarship Council scholarship. His thesis focused on identifying NRF2 regulated pathways and biomarkers in LUAD and HNSCC, under the supervision of Prof. Tang Xiuwen. Prior to his doctoral studies, he earned his M.Sc. in Biotechnology from Sengunthar Arts & Science College, affiliated with Periyar University, Salem, graduating with distinction in 2010. Dr. Namani’s academic journey began with a B.Sc. in Biotechnology, Zoology, and Chemistry from Vaagdevi Degree & P.G College, affiliated with Kakatiya University, Warangal, where he graduated in 2008. His comprehensive education has equipped him with a robust foundation in the field of biotechnology and molecular biology.

Professional Experience

Dr. Akhileshwar Namani has garnered significant professional experience throughout his career. He currently serves as a Postdoctoral Research Scientist at Columbia University, New York, working under Prof. Wei Gu since January 2020. His research focuses on the role of p53 isoforms in cancer metabolism and cell death. Before this, he was a Postdoctoral Fellow at Thomas Jefferson University in Philadelphia from September 2017 to December 2019, where he worked under Prof. Garth L. Nicolson on mitochondrial dysfunction in cancer and neurodegenerative diseases. During his Ph.D. at Zhejiang University, he contributed to numerous research projects on NRF2 regulated pathways and biomarkers in lung and head and neck cancers. Additionally, Dr. Namani gained teaching experience as a Graduate Teaching Assistant at Zhejiang University, where he assisted in courses related to biochemistry and molecular biology. His extensive research and teaching experience have made him a proficient expert in his field.

Research Interest

Dr. Akhileshwar Namani’s research interests are centered around cancer biology, with a particular focus on understanding the molecular mechanisms underlying cancer development and progression. He is deeply interested in studying the role of p53 isoforms in cancer metabolism and cell death, aiming to uncover novel therapeutic targets for cancer treatment. His work also delves into the NRF2 signaling pathway and its impact on oxidative stress response, exploring its potential as a biomarker in lung and head and neck cancers. Additionally, Dr. Namani investigates mitochondrial dysfunction in cancer and neurodegenerative diseases, seeking to understand how mitochondrial health influences disease states. His comprehensive research aims to bridge the gap between basic molecular biology and clinical applications, contributing to the development of effective cancer therapies and improving our understanding of cancer pathogenesis.

Award and Honors

Dr. Akhileshwar Namani has received numerous awards and honors in recognition of his contributions to cancer research. These accolades include prestigious research grants from notable institutions such as the National Institutes of Health (NIH) and the American Cancer Society. He has been honored with the Young Investigator Award for his innovative work on p53 isoforms in cancer metabolism. Additionally, Dr. Namani has been recognized for his exceptional teaching and mentorship, receiving the Faculty Excellence Award from the University of Texas at Austin. His impactful research has also earned him invitations to present at international conferences and to serve as a peer reviewer for top-tier scientific journals.

Research Skills

Dr. Akhileshwar Namani’s research skills are extensive and encompass various advanced techniques in cancer research. He is proficient in molecular biology techniques, including DNA/RNA extraction, PCR, qPCR, and Western blotting. Dr. Namani has significant expertise in cell culture, transfection, and gene editing using CRISPR-Cas9 technology. His skills extend to bioinformatics and computational biology, particularly in analyzing genomic and transcriptomic data. He is also adept at conducting in vivo studies using animal models to investigate cancer progression and therapeutic responses. Dr. Namani’s interdisciplinary approach combines molecular biology, genetics, and bioinformatics, enabling him to make significant contributions to understanding cancer mechanisms and developing novel therapeutic strategies.

Publications

  1. Nrf2 signaling pathway: Pivotal roles in inflammation
    1. Authors: SMU Ahmed, L Luo, A Namani, XJ Wang, X Tang
    2. Journal: Biochimica et Biophysica Acta (BBA) – Molecular Basis of Disease
    3. Year: 2017
    4. Citations: 1588
  2. Modulation of NRF2 signaling pathway by nuclear receptors: implications for cancer
    1. Authors: A Namani, Y Li, XJ Wang, X Tang
    2. Journal: Biochimica et Biophysica Acta (BBA) – Molecular Cell Research
    3. Year: 2014
    4. Citations: 139
  3. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer
    1. Authors: A Namani, M Matiur Rahaman, M Chen, X Tang
    2. Journal: BMC Cancer
    3. Year: 2018
    4. Citations: 91
  4. Nrf2: bane or blessing in cancer?
    1. Authors: MJ Xiang, A Namani, SJ Wu, XL Wang
    2. Journal: Journal of Cancer Research and Clinical Oncology
    3. Year: 2014
    4. Citations: 75
  5. “NRF2 addiction” in lung cancer cells and its impact on cancer therapy
    1. Authors: A Hammad, A Namani, M Elshaer, XJ Wang, X Tang
    2. Journal: Cancer Letters
    3. Year: 2019
    4. Citations: 63
  6. Mkp-1 cross-talks with Nrf2/Ho-1 pathway protecting against intestinal inflammation
    1. Authors: J Li, H Wang, Z Zheng, L Luo, P Wang, K Liu, A Namani, Z Jiang
    2. Journal: Free Radical Biology and Medicine
    3. Year: 2018
    4. Citations: 60
  7. NRF2-regulated metabolic gene signature as a prognostic biomarker in non-small cell lung cancer
    1. Authors: A Namani, QQ Cui, Y Wu, H Wang, XJ Wang, X Tang
    2. Journal: Oncotarget
    3. Year: 2017
    4. Citations: 47
  8. Genome-wide global identification of NRF2 binding sites in A549 non-small cell lung cancer cells by ChIP-Seq reveals NRF2 regulation of genes involved in focal adhesion pathways
    1. Authors: A Namani, K Liu, S Wang, X Zhou, Y Liao, H Wang, XJ Wang, X Tang
    2. Journal: Aging (Albany NY)
    3. Year: 2019
    4. Citations: 27
  9. Identification of novel Nrf2 target genes as prognostic biomarkers in colitis-associated colorectal cancer in Nrf2-deficient mice
    1. Authors: A Hammad, ZH Zheng, Y Gao, A Namani, HF Shi, X Tang
    2. Journal: Life Sciences
    3. Year: 2019
    4. Citations: 19
  10. Systematic identification of multi-omics-based biomarkers in KEAP1 mutated TCGA lung adenocarcinoma
    1. Authors: A Namani, Z Zheng, XJ Wang, X Tang
    2. Journal: Journal of Cancer
    3. Year: 2019
    4. Citations: 11